Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.9360 (-1.28%) ($5.8480 - $6.1600) on Tue. Dec. 31, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.53% (three month average) | RSI | 39 | Latest Price | $5.9360(-1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.2% a day on average for past five trading days. | Weekly Trend | EYES declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) IGOV(8%) TAN(8%) UNG(8%) FIVG(4%) FXI(4%) | Factors Impacting EYES price | EYES will decline at least -1.765% in a week (0% probabilities). BND(-8%) XLK(-7%) QQQ(-7%) XLP(-6%) VUG(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.765% (StdDev 3.53%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
1 - 5 Day Possible Target | $-1.76(-129.65%) | Resistance Level | $6.24 | 5 Day Moving Average | $6(-1.07%) | 10 Day Moving Average | $6.08(-2.37%) | 20 Day Moving Average | $6.24(-4.87%) | To recent high | -19.2% | To recent low | 2.3% | Market Cap | $1.896b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |